Yili Lee

Deputy Chairman

Maywufa Biopharma Group.

General Manager

Amcad BioMed Ltd.

Experience

•Deputy chairman, Maywufa Biopharma Group is one of the reputable biotech conglomerates in TW, established for nearly 40 years. The group‘s business mainly involves in consumer products, pharmaceutical medicine and medical device development.

    –  Maywufa Company Ltd. engages in the distribution of pharmaceuticals as well as sales and manufacture of hair care products.

    –  PhytoHealth Corporation is developing botanical new drug.

    –  AmCad BioMed Corporation is currently developing first-in-class Computer-Aided Detection and Diagnosis (CADe/CADx) software device. AmCad is a world leader in the development of CAD device for ultrasound images of thyroid nodules.  AmCAD-UT Detection has obtained US FDA 510(k) Clearance and CE Mark approval.

All three entities are public listed companies in TW. •Supervisor of  Taiwan Bio Industry Organization •Top 10 Women Leaders in Biopharma Industry of Taiwan 2016 •Director, International Global Corporate, Standard Chartered Bank/Vice President,Credit Agricole Corporate and Investment Bank/Manager, Corporate Banking Group,Citibank, N.A.

Media Report

•SETN.COM

      http://www.setn.com/News.aspx?NewsID=172444 •Apple Daily

https://tw.appledaily.com/new/realtime/20161219/1015765/ •Mirror Media

https://www.mirrormedia.mg/story/20171101bus005/

      https://www.mirrormedia.mg/story/20171101bus006/ •Economic daily News

https://money.udn.com/money/story/5612/3098843

Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.